Aug 9, 2019, 01:00 by admin admin

The opioid epidemic continued throughout the United States in 2017. State legislatures have remained engaged on this issue, with every state enacting some type of measure supporting prevention, treatment, or recovery in the past two years.

Aug 9, 2019, 01:00 by admin admin

Dr. Ilse Levin and Kelly Corredor attended the AMA's 2020 National Advocacy Conference.

Aug 9, 2019, 01:00 by admin admin

The Partnership to Amend 42 CFR Part 2 sent a letter urging Senator Lamar Alexander to help align 42 CFR Part 2 with HIPAA.

Aug 9, 2019, 01:00 by admin admin

The Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) state and local health departments, and other clinical and public health partners are investigating a national outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI). As of December 10, 2019, a total of 2,409 hospitalized EVALI cases have been reported to CDC from all 50 states, the District of Columbia, and two U.S. territories (Puerto Rico and U.S. Virgin Islands). Fifty-two deaths have been confirmed in 26 states and the District of Columbia.

Aug 9, 2019, 01:00 by admin admin

On April 11, 2017, ASAM and 19 members of the Coalition to Stop Opioid Overdose sent a letter to the Chairmen and Ranking Members of the House and Senate Committees on Appropriations requesting full funding for the Comprehensive Addiction and Recovery Act (CARA) in the Fiscal Year 2017 and 2018 appropriations bills.

Aug 9, 2019, 01:00 by admin admin

Today the American Society of Addiction Medicine (ASAM) submitted a letter to the House Committee on Energy and Commerce as it considers legislation to address the opioid misuse, addiction, and overdose epidemic. The letter, submitted to Chairman Greg Walden (R-OR) and Ranking Member Frank Pallone (D-NJ), urges the Committee to approve bills that expand the provision of evidence-based treatment, strengthen America’s addiction treatment infrastructure, and bolster the nation’s addiction treatment workforce.

Aug 9, 2019, 01:00 by admin admin

Updated definition of addiction to explain more fully the complexity of this chronic disease with the intent of driving a bold and comprehensive national response.

Aug 9, 2019, 01:00 by admin admin

The American Society of Addiction Medicine is pleased to hear that The ASAM Criteria was included in today’s discussion about solutions to combat the opioid misuse and overdose crisis. Addressing this public health emergency will require systemic and sustainable changes to our addiction treatment infrastructure and workforce, as well as expanded access to comprehensive, evidenced-based treatment that includes all levels of care. 

Aug 9, 2019, 01:00 by admin admin

On May 16, the Food and Drug Administration (FDA) announced its approval Lucemyra, the first non-opioid treatment for management of opioid withdrawal symptoms. Lucemyra (lofexidine hydrochloride) reduces the release of norepinephrine and can be used to lessen the severity of withdrawal symptoms that may occur after the discontinuation of opioid use.

Aug 9, 2019, 01:00 by admin admin

ASAM sent letters of support for the Removing Barriers to Medicaid and CHIP Addiction Treatment Act and the Medicaid Coverage for Addiction Recovery Treatment Act. These bills would work to repeal Medicaid Institutions for the Mental Diseases (IMD) exclusion for mental health and substance use disorder residential treatment facilities. 

Aug 9, 2019, 01:00 by admin admin

ASAM took the opportunity to advocate for standardization of addiction treatment when MACPAC released its request for information on the Medicaid IMD Additional INFO Act.

Aug 9, 2019, 01:00 by admin admin

The Coalition to Stop Opioid Overdose (CSOO) welcomes HIV Alliance as a new member of the coalition. HIV Alliance was formed in 1994 to support individuals living with HIV/AIDS and prevent new HIV infections.

Aug 9, 2019, 01:00 by admin admin

Dr. Kelly J. Clark, president of ASAM, participated in a congressional roundtable sponsored by the House Bipartisan Heroin and Opioid Task Force. At the event, she urged lawmakers to make strategic investments in the substance use disorder (SUD) treatment workforce in order to close the addiction treatment gap and ensure the millions of Americans living with SUD are able to receive the care they need.

Aug 9, 2019, 01:00 by admin admin

The Coalition to Stop Opioid Overdose (CSOO) is proud to announce A New PATH (Parents for Addiction Treatment and Healing) as a new member of the coalition. A New PATH works with families, individuals in recovery, healthcare professionals and community leaders to reduce the stigma associated with addictive illness through education and compassionate support and to advocate for therapeutic rather than punitive drug policies.

Aug 9, 2019, 01:00 by admin admin

The Partnership to Amend 42 CFR Part 2 sent a letter urging Senator Lamar Alexander to use the Lower Health Care Costs Act of 2019 as an opportunity to align 42 CFR Part 2 with HIPAA.

Aug 9, 2019, 01:00 by admin admin

Dr. Shawn Ryan appeared before the Kentucky House Committee on Banking and Insurance in support of HB389.

Aug 9, 2019, 01:00 by admin admin

Yngvild Olsen, MD, MPH urged lawmakers to expand access to evidence-based addiction treatment and invest more resources to address the addiction and overdose crisis during today’s House Committee on Oversight and Reform Hearing .

Jul 19, 2019, 01:00 by admin admin

Friends of HRSA sent a letter to legislators urging them to appropriate $8.8 billion for discretionary Health Resources and Services Administration programs for FY2021.

Jul 19, 2019, 01:00 by admin admin

ASAM applauds the introduction of the Cannabidiol and Marijuana Research Expansion Act, which would enable researchers to better study cannabis.

Jul 19, 2019, 01:00 by admin admin

ASAM supports the introduction of the Medical Marijuana Research Act, which would enable researchers to better study cannabis.